GGrantIndex
← Search

Regional Oncology Research Center (Heterogeneity)

$100,000P30FY2024CANIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications, trials & patents

Trial NCT02989636Trial NCT02516670Trial NCT02491411Trial NCT02489357Trial NCT02029950Trial NCT01935947Trial NCT01870596Trial NCT01783171Trial NCT01757639Trial NCT01578109Trial NCT01349972Trial NCT01349959Trial NCT01330173Trial NCT01264432Trial NCT01207726Trial NCT01207687Trial NCT01139970Trial NCT01132573Trial NCT01061749Trial NCT00971737Trial NCT00963807Trial NCT00899951Trial NCT00899548Trial NCT00898482Trial NCT00897338Trial NCT00897273Trial NCT00847171Trial NCT00795002Trial NCT00727441Trial NCT00673569Trial NCT00670917Trial NCT00660348Trial NCT00641303Trial NCT00641147Trial NCT00631137Trial NCT00616967Trial NCT00602771Trial NCT00588991Trial NCT00566098Trial NCT00524017Trial NCT00499733Trial NCT00499486Trial NCT00493025Trial NCT00492921Trial NCT00489281Trial NCT00478062Trial NCT00478010Trial NCT00471653Trial NCT00470093Trial NCT00469820Trial NCT00445484Trial NCT00433472Trial NCT00425477Trial NCT00407966Trial NCT00401024Trial NCT00389610Trial NCT00387465Trial NCT00381550Trial NCT00373191Trial NCT00369681Trial NCT00368914Trial NCT00363649Trial NCT00361296Trial NCT00356928Trial NCT00354640Trial NCT00343447Trial NCT00336063Trial NCT00334542Trial NCT00324870Trial NCT00313560Trial NCT00311623Trial NCT00305760Trial NCT00303927Trial NCT00293410Trial NCT00293397Trial NCT00293280Trial NCT00290732Trial NCT00287989Trial NCT00287872Trial NCT00281970Trial NCT00281866Trial NCT00278200Trial NCT00278161Trial NCT00278109Trial NCT00276744Trial NCT00276601Trial NCT00276588Trial NCT00274768Trial NCT00265915Trial NCT00265837Trial NCT00262834Trial NCT00258206Trial NCT00258180Trial NCT00255775Trial NCT00255710Trial NCT00245115Trial NCT00244959Trial NCT00242996Trial NCT00238368Trial NCT00238277

Abstract

PROJECT SUMMARY/ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 24-032. Black women have the highest breast cancer mortality rate and shortest overall survival among all racial/ethnic groups of women in the United States. Adverse social determinants of health (SDoH) (e.g., structural racism) are documented sources of racial disparities in breast cancer. However, research studies examining the mechanistic pathways of these associations and those examining within-group differences among Black women are lacking. This study seeks to overcome these limitations of current research by examining the extent to which SDoH measures are associated with inflammatory biomarkers among Black women. We will recruit a socio-demographically heterogeneous sample of Black breast cancer survivors from Maryland. Participants will provide survey data, blood samples, and qualitative data. Integrating these data, we will assess associations and generate new hypotheses about the influence of adverse SDoH on breast cancer among Black women. In Aim 1 of the study, we will examine associations between SDoH, patient-reported outcomes, and inflammation-related protein biomarkers in a sample of 100 socio-demographically diverse Black BC survivors. We will employ statistical and laboratory analyses to examine associations of SDoH measures and health-related quality of life with inflammatory biomarkers overall and explore stratifications by measures of individual socioeconomic position. In Aim 2 of the study, we will conduct eight focus groups with a subset of participants from Aim 1. Focus groups will be homogeneous by age group and area of residence to more comprehensively understand within-group lived experiences related to SDoH and breast cancer. We will integrate qualitative analyses with findings from Aim 1 using a mixed methods analytic approach. The study is strongly aligned with NOT-CA-24-032 and with the priorities of the parent grant (P30CA006973). Findings will provide insight into how social factors can impact inflammation and cancer outcomes in varied socio-demographic subgroups of Black women.

View original record on NIH RePORTER →
Regional Oncology Research Center (Heterogeneity) · GrantIndex